Leishmaniasis: studying the body's immune response
Part of Infections, Skin clinical trials.
This study looks at how the immune system reacts to Leishmania infection and searches for new ways to diagnose the disease. It may help develop better tests for leishmaniasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed Leishmania infection (by a doctor or lab tests)
- You are 18 years or older
- You live in Italy or Sudan
- Your blood or tissue samples can be used for research (consent given)
- For volunteers without infection: no history of Leishmania and negative lab tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This study checks whether workers in Montpellier's zoo, green spaces, or Ecolothèque have been exposed to germs from animals. It uses a blood test to look for past infections, which may help protect workers in similar jobs.
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
This study looks at people diagnosed with visceral leishmaniasis, a serious infection caused by a parasite. It aims to learn more about the condition and how it affects people in the Emilia-Romagna region.
This trial uses stored samples to see if a newer test (PCR) is as good as standard tests at detecting three infections: Pneumocystis (a lung infection), malaria, and leishmaniasis. It does not involve new treatments.
Hear when a new Leishmaniasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.